Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
584.2 SEK | +1.61% |
|
+3.72% | +8.92% |
05-23 | Camurus' Rare Growth Disorder Drug Accepted for Review in EU | MT |
05-23 | Camurus Receives EMA Acceptance of MAA Filing for Octreotide SC Depot for the Treatment of Acromegaly | CI |
- Stock Market
- Equities
- CAMX Stock
- News Camurus AB
- Transcripts